JPRN-UMIN000009170CompletedPhase 4
Evaluation of Cardiac Sympathetic Nerve Activity and Aldosterone Suppression in Patients With Decompensated Acute Heart Failure on the Treatment Containing Intravenous Atrial Natriuretic Peptide - ANP in Decompensated AHF
Kitakanto Cardiovascular Hospital0 sites200 target enrollmentStarted: October 23, 2012Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 200
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) Cardiogenic shock or hypotension 2) History of myocardial infarction or coronary artery disease 3) Severe heart failure requiring mechanical support (intraaortic balloon pumping, left ventricular assist device, or cardiac resynchronization therapy) 4) Requiring heart transplantation
Investigators
Similar Trials
Completed
Not Applicable
Cardiac sympathetic nervous system function and activity as a predictor for appropriate ICD therapy in patients with chronic heart failureheart failure and fatal arrhytmias10007521sudden cardiac deathNL-OMON33730Academisch Medisch Centrum300
Completed
Not Applicable
Study on cardiac sympathetic nerve function in the diagnosis of dementia with Lewy bodies and Alzheimer's diseaseDementia with Lewy bodies Alzheimer's diseaseJPRN-UMIN000003419Department of Neurology and Neurobiology of Aging, Kanazawa University School of Medical Science140
Completed
Not Applicable
Muscle Sympathetic Nerve Activity and Cardiovascular Organ Damage in Patients with Chronic Kidney Disease and Hypertensio10029149HypertensieChronic Renal DiseaseChronic kidney diseaseNL-OMON31233Academisch Medisch Centrum60
Completed
Phase 4
Prognostic Value of Cardiac Sympathetic Nerve Activity Evaluated by 123I-Metaiodobenzylguanidine Imaging in Patients with ST-Segment Elevation Myocardial InfarctioST-segment elevation myocardial infarctionJPRN-UMIN000001380Kitakanto Cardiovascular Hospital200
Completed
Not Applicable
Evaluation of myocardial sympathetic activity and myocardial blood flow assessed by the C-11 hydroxyephedrine and O-15 water PET/CT in patients who underwent implantable cardioverter-defibrillator for the treatment of ventricular arrhythmia.ventricular arrhythmiaJPRN-UMIN000012824Hokkaido University Hospital, Department of Cardiology